Box score
TheRas, Inc.
Reported $200M sold in a new Form D filed May 15, 2024 (Palo Alto, California).
- Biggest raise
- $200M filed May 15, 2024
- League
- Bio & Health Biotechnology
- Based in
- Palo Alto, California
- Season rank
- #18 of 1,389 in the Bio & Health League; #76 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-05-15 | New notice | $200M | $200M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2022953.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Cidara Therapeutics, Inc. | Bio & Health | $240M |
| 2 | Candid Therapeutics, Inc. rookie | Bio & Health | $206M |
| 3 | Tyra Biosciences, Inc. rookie | Bio & Health | $200M |
| 4 | BioAge Labs, Inc. rookie | Bio & Health | $194M |
| 5 | Surrozen, Inc./DE rookie | Bio & Health | $193M |
| 6 | TORL Biotherapeutics LLC rookie | Bio & Health | $158M |